Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute

Research keywordsendometrial cancer・ovarian cancer cytoreduction・HPV genotype risk・Lgr4 signaling・cancer stem cell phenotype・microRNA 101・gynecologic oncology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells2014 · ONCOTARGET, 5, 15, 6049, 6062, 2014年08月,
• Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials2014 · ANNALS OF SURGICAL ONCOLOGY, 21, 8, 2755, 2761, 2014年08月,
• A Naturally Occurring Lgr4 Splice Variant Encodes a Soluble Antagonist Useful for Demonstrating the Gonadal Roles of Lgr4 in Mammals2014 · PLOS ONE, 9, 9, e106804, 2014年09月,
• Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer2014 · EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41, 3, 446, 451, 2014年03月,

• Official profile